Bavituximab, also TRWH-783, represents a exciting treatment strategy targeting phosphatidylserine (PS). PS is normally an cellular lipid present inside cell membranes; however, it's frequently displayed on the surface https://shaunasjuf976623.aboutyoublog.com/profile